[
  {
    "ts": null,
    "headline": "AbbVie Inc. stock underperforms Tuesday when compared to competitors",
    "summary": "AbbVie Inc. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=f0bc67b8356f6ecfe9ca154aab2aaec8f5c8c71f62c34e8082233e7d2edf5ad1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736872320,
      "headline": "AbbVie Inc. stock underperforms Tuesday when compared to competitors",
      "id": 132408176,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=f0bc67b8356f6ecfe9ca154aab2aaec8f5c8c71f62c34e8082233e7d2edf5ad1"
    }
  },
  {
    "ts": null,
    "headline": "Evolus: Still Bullish, But Business Faces Tricky Challenges In '25",
    "summary": "Evolus faces sector instability but shows strong growth potential. Learn why EOLS stock remains a âBuyâ despite challenges, with a positive Q4 outlook.",
    "url": "https://finnhub.io/api/news?id=0484ed55d50a362280a511a8cb06114313b3adc75ae53b68dc28653929ba0fd6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736863240,
      "headline": "Evolus: Still Bullish, But Business Faces Tricky Challenges In '25",
      "id": 132395221,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/166621400/image_166621400.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Evolus faces sector instability but shows strong growth potential. Learn why EOLS stock remains a âBuyâ despite challenges, with a positive Q4 outlook.",
      "url": "https://finnhub.io/api/news?id=0484ed55d50a362280a511a8cb06114313b3adc75ae53b68dc28653929ba0fd6"
    }
  },
  {
    "ts": null,
    "headline": "Revance Therapeutics: The Takeover Saga Continues As Teoxane Enters The Fray",
    "summary": "Financial issues and competition plague Revance Therapeutics, Inc. as takeover offers and legal battles overshadow its future potential. Click for this RVNC update.",
    "url": "https://finnhub.io/api/news?id=782f433da49c04f38790ff176a83b437dbd160dd1648b2987b85dbb5d2aff86d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736852697,
      "headline": "Revance Therapeutics: The Takeover Saga Continues As Teoxane Enters The Fray",
      "id": 132394470,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2186829647/image_2186829647.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Financial issues and competition plague Revance Therapeutics, Inc. as takeover offers and legal battles overshadow its future potential. Click for this RVNC update.",
      "url": "https://finnhub.io/api/news?id=782f433da49c04f38790ff176a83b437dbd160dd1648b2987b85dbb5d2aff86d"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Has Immense Cash Flow Potential",
    "summary": "AbbVie's strong financials and potential for cash flow make it a valuable investment, despite risks from patent expirations. Read more about ABBV stock here.",
    "url": "https://finnhub.io/api/news?id=537e8f7e60b15301ec90ca54b99308224f06d8a464e24f810982dc991f2eedf4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736831289,
      "headline": "AbbVie Has Immense Cash Flow Potential",
      "id": 132392573,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2175801616/image_2175801616.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "AbbVie's strong financials and potential for cash flow make it a valuable investment, despite risks from patent expirations. Read more about ABBV stock here.",
      "url": "https://finnhub.io/api/news?id=537e8f7e60b15301ec90ca54b99308224f06d8a464e24f810982dc991f2eedf4"
    }
  }
]